Evaluation of gabapentin in an outpatient and office-based sample of epilepsy patients

Journal of Epilepsy

Volumn 11, Issue 3, 1998, Pages 130-135

  Harden, Cynthia L ^a   Hosain, Syed ^a   Nikolov, Blagovest ^a   Labar, Douglas R ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Adjunctive therapy; Epilepsy; Gabapentin; Seizures

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; MESUXIMIDE; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DOSE RESPONSE; DRUG EFFICACY; EPILEPSY; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; VERTIGO; VISUAL IMPAIRMENT; WEIGHT GAIN;

EID: 0031862720     PISSN: 08966974     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6974(97)00140-0     Document Type: Article

References (13)

1. Btaiche IF, Woster PS. Gabapentin and lamotrigine Novel antiepileptic drugs . Am J Health Syst Pharm. 52:1995;61-69.
2. Mattson RH. Drug treatment of partial epilepsy. Chauvel P, Delgada-Escueta AV, et al. Advances in neurology (vol. 57). 1992;643-650 Raven Press, New York.
3. Fisher RS. Emerging antiepileptic drugs. Neurology. 43:(suppl 5):1993;S12-S20.
4. Gabapentin in partial epilepsy. Lancet. 335:1990;1114-1117.
5. Gabapentin as add-on therapy in refractory partial epilepsy A double-blind, placebo-controlled, parallel-group study . Neurology. 432:1993;2292-2298.
6. Anhut H, Achman P, Feurerstein TJ, Sauermann W, Saunders M, Schmidt B. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures A double-blind, placebo-controlled study . Epilepsia. 35:1994;795-801.
7. Sivenius J, Ylinen A, Kalviainen R, Riekkinen PJ. Long-term study with gabapentin patients with drug-resistant epileptic seizures. Arch Neurol. 51:1994;1047-1050.
8. Handforth A, Treiman DM. Efficacy and tolerance of long-term, high-dose gabapentin Additional observations . Epilepsia. 35:1994;1032-1037.
9. Morell M, McLean M, Willmore J, Lagnus-Miller Leslie, Podolnik PB, Rose-Legatt A. Efficacy of gabapentin (Neurontin) as add-on therapy for patients with partial epilepsy (abstract). Neurology. 48:(suppl 2):1997;A335.
10. Bergey GK, Morris HH, Rosendeld W, Blume WT, Penovich PE, Morell MJ, Leiderman DB, Crockatt JG, LaMoreaux L, Garofalo E, Pierce M. Gabapentin monotherapy I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures . Neurology. 49:1997;739-745.
11. Beydoun A, Fischer J, Labar DR, Harden C, Cantrell D, Uthman BM, Sackellares JC, Abou-Khalil B, Ramsay RE, Hayes A, Greiner M, Garofalo E, Pierce M. Gabapentin monotherapy II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures . Neurology. 49:1997;746-752.
12. Leiderman D, Garofalo E, LaMoreaux L. Gabapentin patients with absence seizures Two double-blind, placebo controlled studies . Epilepsia. 34:(suppl 6):1993;45.
13. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alph2delta subunit of a calcium channel. J Biol Chem. 271:1996;5768-5776.